Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Janna Buzitskaya"'
Autor:
Anna-Polina Shurygina, Natalia Zabolotnykh, Tatiana Vinogradova, Berik Khairullin, Markhabat Kassenov, Ainur Nurpeisova, Gulbanu Sarsenbayeva, Abylai Sansyzbay, Kirill Vasilyev, Janna Buzitskaya, Andrey Egorov, Marina Stukova
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 8, p 7439 (2023)
Tuberculosis is a major global threat to human health. Since the widely used BCG vaccine is poorly effective in adults, there is a demand for the development of a new type of boost tuberculosis vaccine. We designed a novel intranasal tuberculosis vac
Externí odkaz:
https://doaj.org/article/5abca10aa0904b41af1783533ed09600
Autor:
Kirill Vasilyev, Anna-Polina Shurygina, Natalia Zabolotnykh, Mariia Sergeeva, Ekaterina Romanovskaya-Romanko, Anastasia Pulkina, Janna Buzitskaya, Marine Z. Dogonadze, Tatiana I. Vinogradova, Marina A. Stukova
Publikováno v:
Vaccines, Vol 9, Iss 11, p 1273 (2021)
BCG is the only licensed vaccine against Mycobacterium tuberculosis (M.tb) infection. Due to its intramuscular administration route, BCG is unable to induce a local protective immune response in the respiratory system. Moreover, BCG has a diminished
Externí odkaz:
https://doaj.org/article/0834a9890ac0450ea8bb455b9f114e17
Autor:
Mariia Sergeeva, Ekaterina Romanovskaya-Romanko, Natalia Zabolotnyh, Anastasia Pulkina, Kirill Vasilyev, Anna Polina Shurigina, Janna Buzitskaya, Yana Zabrodskaya, Artem Fadeev, Andrey Vasin, Tatiana I. Vinogradova, Marina A. Stukova
Publikováno v:
Vaccines, Vol 9, Iss 4, p 394 (2021)
New strategies providing protection against tuberculosis (TB) are still pending. The airborne nature of Mycobacterium tuberculosis (M.tb) infection assumes that the mucosal delivery of the TB vaccine could be a more promising strategy than the system
Externí odkaz:
https://doaj.org/article/003c48119fca443ab1736fbff8f4ec55
Autor:
Natalia Zabolotnykh, Marine Dogonadze, Mariia Sergeeva, Anna-Polina Shurygina, A. A. Pulkina, Tatiana Vinogradova, Kirill Vasilyev, Marina Stukova, Ekaterina Romanovskaya-Romanko, Janna Buzitskaya
Publikováno v:
Vaccines
Vaccines, Vol 9, Iss 1273, p 1273 (2021)
Volume 9
Issue 11
Vaccines, Vol 9, Iss 1273, p 1273 (2021)
Volume 9
Issue 11
BCG is the only licensed vaccine against Mycobacterium tuberculosis (M.tb) infection. Due to its intramuscular administration route, BCG is unable to induce a local protective immune response in the respiratory system. Moreover, BCG has a diminished
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::231eca967dce4abcb95aa28a53c40fa7
http://europepmc.org/articles/PMC8626046
http://europepmc.org/articles/PMC8626046
Autor:
Andrey V. Vasin, Yana A. Zabrodskaya, Mariia Sergeeva, Tatiana Vinogradova, Marina Stukova, A. A. Pulkina, Natalia Zabolotnyh, Artem Fadeev, Anna Polina Shurigina, Ekaterina Romanovskaya-Romanko, Kirill Vasilyev, Janna Buzitskaya
Publikováno v:
Vaccines
Vaccines, Vol 9, Iss 394, p 394 (2021)
Volume 9
Issue 4
Vaccines, Vol 9, Iss 394, p 394 (2021)
Volume 9
Issue 4
New strategies providing protection against tuberculosis (TB) are still pending. The airborne nature of Mycobacterium tuberculosis (M.tb) infection assumes that the mucosal delivery of the TB vaccine could be a more promising strategy than the system
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c20bc4c7f97404ef40d8a4bd0f365b3
https://doi.org/10.3390/vaccines9040394
https://doi.org/10.3390/vaccines9040394